Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
SGO 2023
Questions discussed in this category
What are your top takeaways from SGO 2023?
7 Answers available
15871
Papers discussed in this category
N Engl J Med, 2023 Mar 27
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med, 2023 Mar 27
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Related Topics
Radiation Oncology
Gynecologic Oncology
Endometrial Cancer
Cervical Cancer
Medical Oncology
Ovarian Cancer
Vulvar Cancer
Survivorship
Financial toxicity
Gestational Trophoblastic Disease
